• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-017
Device Problem Biocompatibility (2886)
Patient Problem Thrombosis/Thrombus (4440)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, a (b)(6) female with sinus rhythm who was implanted with a 17mm amplatzer septal occluder.An event of thrombus formation was reported.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
The article, "angioscopic evaluation of atrial septal defect closure device neo-endothelialization", was reviewed.This research article presents a case study on a (b)(6) female with sinus rhythm who was implanted with a 17mm amplatzer septal occluder.The patient was on aspirin and clopidogrel antithrombotic therapy after the procedure.6 months post-procedure the patient underwent angioscopy to evaluate new-endothelialization of the closure device.Thrombus formation was noted on the amplatzer septal occluder.No additional information was provided.The article concluded that neo-endothelialization on the closure devices varied 6 months after implantation.Notably, poor endothelialization and thrombus attachment were observed around the central areas and on the larger devices.The primary and correspondence author of the article is yasuhiro tanabe, md, phd, division of cardiology, department of internal medicine, st.Marianna university school of medicine, 2-16-1 (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key12763302
MDR Text Key282008834
Report Number2135147-2021-00461
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 11/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-ASD-017
Device Catalogue Number9-ASD-017
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/08/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age75 YR
Patient SexFemale
-
-